In The Spotlight


InflaRx-USD-022218.jpg Shares of Inflarx NV (IFRX) are up more than 50% year-to-date while the iShares NASDAQ Biotechnology Index (ETF) has gained only 2% during the same period.

CBIO-Trade-Hike-020918.jpg Shares of Catalyst Biosciences Inc. (CBIO) are up an impressive 100% year-to-date in sharp contrast to the NASDAQ Biotechnology Index, which is down nearly 2% during the same period.

SYNERGY-Loans-020518.jpg For Synergy Pharmaceuticals Inc. (SGYP), whose shares are down 11% year-to-date, the worst may be behind it. With Synergy Pharma taking all steps to effectively manage costs while simultaneously investing in strategic initiatives that deliver growth to the Company's top-line, it is worth keeping an eye on this stock.

Iovancebio-013018.jpg Shares of Iovance Biotherapeutics Inc. (IOVA) are up 80% since the start of the year while the iShares Nasdaq Biotechnology Index (ETF) (IBB) has risen a mere 11% during the same period.

Follow RTT